Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRPM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNH5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
SPHK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACADVL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGDIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MC1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFXN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YWHAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM259 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLI4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on